Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Assets:
Cash and cash equivalents	$ 11,329	$ 8,453
Investments	2,629	2,145
Accounts receivable, net	40,309	39,779
Inventories	17,622	19,246
Other current assets	3,457	5,091
Total current assets	75,346	74,714
Long-term investments	33,247	32,669
Property and equipment, net	13,168	13,083
Operating lease right-of-use assets	14,451	14,973
Goodwill	85,478	85,478
Intangible assets, net	24,644	25,508
Other assets	7,434	7,113
Total assets	253,768	253,538
Liabilities:
Accounts payable	17,167	17,641
Pharmacy claims and discounts payable	26,203	26,344
Health care costs payable	16,313	15,399
Accrued expenses and other current liabilities	22,477	22,387
Other insurance liabilities	1,009	1,116
Current portion of operating lease liabilities	1,914	1,737
Current portion of long-term debt	1,958	4,068
Total current liabilities	87,041	88,692
Long-term operating lease liabilities	12,982	13,643
Long-term debt	59,452	60,502
Deferred income taxes	3,766	3,832
Other long-term insurance liabilities	4,516	4,716
Other long-term liabilities	6,112	6,771
Total liabilities	173,869	178,156
Shareholders’ equity:
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	0	0
Common stock, par value $0.01: 3,200 shares authorized; 1,795 shares issued and 1,278 shares outstanding as of June 30, 2026 and 1,787 shares issued and 1,271 shares outstanding as of December 31, 2025 and capital surplus	50,968	50,402
Treasury stock, at cost: 517 and 516 shares as of June 30, 2026 and December 31, 2025	(36,852)	(36,790)
Retained earnings	65,398	61,196
Accumulated other comprehensive income	188	406
Total CVS Health shareholders’ equity	79,702	75,214
Noncontrolling interests	197	168
Total shareholders’ equity	79,899	75,382
Total liabilities and shareholders’ equity	$ 253,768	$ 253,538